Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Douglas A. McIntyre | Jul 27, 2010 at 8:45 AM EDT

Today’s Best Market Rumors

Updated throughout the day. Genzyme (NASDAQ: GENZ) is considering an offer from Sanofi-Aventis (Reuters) Clayton Dubilier & Rice and Goldman…

Jon C. Ogg | Jul 23, 2010 at 2:15 PM EDT

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in buying the…

Jon C. Ogg | Jul 18, 2010 at 11:56 AM EDT

The Unusual Suspects for the Week Ahead (AAPL, BP, CROX, GE, GOOG, OREX, SWY, SD, VVUS, VOCL, CALL, VG)

This weekend’s edition of The Unusual Suspects includes mostly non-earnings events that will be on deck this coming week and/or…

Jon C. Ogg | Jul 14, 2010 at 11:28 AM EDT

Home Health Care Providers Under Scrutiny (LHCG, AMED, AFAM, GTIV)

Properly used, home health care can save billions of dollars annually in health care expenditures. Sending a patient home and…

Douglas A. McIntyre | Jul 13, 2010 at 5:40 AM EDT

GlaxoSmithKline: Another Drug Company Runs Afoul Of The Truth

GlaxoSmithKline (NYSE: GSK), like a number of pharmaceutical companies before it, has run up against the truth about one of…

Douglas A. McIntyre | Jul 8, 2010 at 4:03 PM EDT

National Employee Morale Day At Merck

Merck & Co., Inc. (NYSE: MRK) will dump 16,000 workers now that its merger with Schering-Plough well along. The company …

Jon C. Ogg | Jul 7, 2010 at 1:21 PM EDT

BioHealth Business Daily (AMGN, SNY, AFFX, CORT, CRIS, CYTR, HGSI, NEXMD, NYMX, XNPT)

Today’s version of the BioHealth Business Daily is a very unusual lot of movers. Some moves are merely in sympathy…

Jon C. Ogg | Jul 6, 2010 at 2:24 PM EDT

More Big Drug & Biotech Mergers Likely (SNY, AMGN, BIIB, GENZ, BSX, JNJ, HGSI, DNDN, AUXL, VRTX, AMLN, LLY, WCRX, CBST)

Sanofi-Aventis SA (NYSE: SNY) was a bit of a stalking horse news item on a week that many investors and…

Douglas A. McIntyre | Jul 6, 2010 at 11:58 AM EDT

This Month’s Biggest Index Losers: Radio, Chinese Advertising, and Cancer Treatment Stocks

Heavy losses were sustained in three Tickerspy indexes over the last 30-day period. This month’s biggest index losers are in radio,…

Jon C. Ogg | Jul 1, 2010 at 12:41 PM EDT

Uncle Sam’s War Against PROVENGE Gets Nasty (DNDN)

If there is one single sector which could be immune to the crummy jobs data, it is biotech. Just don’t…

Jon C. Ogg | Jun 18, 2010 at 2:37 PM EDT

BioHealth Business Daily (AMGN, AMLN, ALKS, DNDN, SNY, GENZ, MIPI)

There are many key movers in today’s BioHealth Business Daily. We have included background data, news, reactions, and added in…

Jon C. Ogg | Jun 8, 2010 at 2:51 PM EDT

Walgreen Vs. CVS Caremark: When Partnerships Turn South (WAG, CVS)

Sometimes little surprises are just as interesting as big ones. For example, Walgreen Co. (NYSE:WAG) has announced that it would…

Jon C. Ogg | Jun 7, 2010 at 1:22 PM EDT

BioHealth Business Daily (ARQL, APPY, BPAX, BMY, CLDX, CELG, DCTH, JAV, KERX, PCYC, TLCR, VVUS)

Today’s edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical…

Jon C. Ogg | Jun 2, 2010 at 2:17 PM EDT

Opportunity Knocks: Turning Around 3 Large Biotechs (AMGN, BIIB, GENZ)

Biotech is the land of promise for emerging players. It is also the land of stagnation for well established and…

Jon C. Ogg | Jun 1, 2010 at 9:25 AM EDT

7 Stocks For The Great Value Hunt (MRK, LLY, EXC, NOC, LLL, NLY, NEU)

Stocks may have bounced from their lows and gone lower of late, but there are still many down and out…

1 … 331 332 333 334 335 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Today’s Best Market Rumors

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

The Unusual Suspects for the Week Ahead (AAPL, BP, CROX, GE, GOOG, OREX, SWY, SD, VVUS, VOCL, CALL, VG)

Home Health Care Providers Under Scrutiny (LHCG, AMED, AFAM, GTIV)

GlaxoSmithKline: Another Drug Company Runs Afoul Of The Truth

National Employee Morale Day At Merck

BioHealth Business Daily (AMGN, SNY, AFFX, CORT, CRIS, CYTR, HGSI, NEXMD, NYMX, XNPT)

More Big Drug & Biotech Mergers Likely (SNY, AMGN, BIIB, GENZ, BSX, JNJ, HGSI, DNDN, AUXL, VRTX, AMLN, LLY, WCRX, CBST)

This Month’s Biggest Index Losers: Radio, Chinese Advertising, and Cancer Treatment Stocks

Uncle Sam’s War Against PROVENGE Gets Nasty (DNDN)

BioHealth Business Daily (AMGN, AMLN, ALKS, DNDN, SNY, GENZ, MIPI)

Walgreen Vs. CVS Caremark: When Partnerships Turn South (WAG, CVS)

BioHealth Business Daily (ARQL, APPY, BPAX, BMY, CLDX, CELG, DCTH, JAV, KERX, PCYC, TLCR, VVUS)

Opportunity Knocks: Turning Around 3 Large Biotechs (AMGN, BIIB, GENZ)

7 Stocks For The Great Value Hunt (MRK, LLY, EXC, NOC, LLL, NLY, NEU)

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Health and Healthcare Articles

All Health and Healthcare Articles

Today’s Best Market Rumors

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

The Unusual Suspects for the Week Ahead (AAPL, BP, CROX, GE, GOOG, OREX, SWY, SD, VVUS, VOCL, CALL, VG)

Home Health Care Providers Under Scrutiny (LHCG, AMED, AFAM, GTIV)

GlaxoSmithKline: Another Drug Company Runs Afoul Of The Truth

National Employee Morale Day At Merck

BioHealth Business Daily (AMGN, SNY, AFFX, CORT, CRIS, CYTR, HGSI, NEXMD, NYMX, XNPT)

More Big Drug & Biotech Mergers Likely (SNY, AMGN, BIIB, GENZ, BSX, JNJ, HGSI, DNDN, AUXL, VRTX, AMLN, LLY, WCRX, CBST)

This Month’s Biggest Index Losers: Radio, Chinese Advertising, and Cancer Treatment Stocks

Uncle Sam’s War Against PROVENGE Gets Nasty (DNDN)

BioHealth Business Daily (AMGN, AMLN, ALKS, DNDN, SNY, GENZ, MIPI)

Walgreen Vs. CVS Caremark: When Partnerships Turn South (WAG, CVS)

BioHealth Business Daily (ARQL, APPY, BPAX, BMY, CLDX, CELG, DCTH, JAV, KERX, PCYC, TLCR, VVUS)

Opportunity Knocks: Turning Around 3 Large Biotechs (AMGN, BIIB, GENZ)

7 Stocks For The Great Value Hunt (MRK, LLY, EXC, NOC, LLL, NLY, NEU)

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income